Insiders · Profile

Gulino Richard L.

SVP, General Counsel & Sec. at Vanda Pharmaceuticals. Filing since 3 Jan 2017. CIK 0001652208

Company
Date
Role
Action
Shares
Amount
Of holding
1 Mar 2018
SVP, General Counsel & Sec.
Sold, plan not stated
3,660
$68.47K
3.1%
2 Jan 2018
SVP, General Counsel & Sec.
Sold, plan not stated
10,367
$157.56K
10.5%
3 Jan 2017
SVP, General Counsel & Sec.
Sold, plan not stated
10,900
$169.09K
54.5%
3 decisions on file.